Jagiellonian University-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2014

  1. A randomised phase 2 study combining LY2181308 sodium (survivin antisense oligonucleotide) with first-line docetaxel/prednisone in patients with castration-resistant prostate cancer

    European Urology, Vol. 65, Núm. 3, pp. 516-520